文献速递肝胆胰外科

可切除胰腺神经内分泌肿瘤的微创与开放远端胰腺切除术:一项倾向性评分匹配的多中心法国对比研究

Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study.
PubMed 文献 · Surgery · 2024-05-25

该回顾性研究纳入法国21个中心2014年1月至2018年12月因可切除胰腺神经内分泌肿瘤行左侧胰腺切除的274例患者,经倾向性评分匹配后比较微创与开放手术。匹配后微创手术与更少出血、更低主要并发症发生率(6% vs 24%;P = .02)及更少术后胃排空延迟相关,5年总生存(79% vs 75%;P = .74)与无复发生存(10% vs 17%;P = .39)相似。作者认为微创手术可安全用于可切除左侧胰腺神经内分泌肿瘤患者。

要点

  • 匹配后微创手术主要并发症发生率为6%,开放手术为24%(P = .02)。
  • 匹配后微创手术出血更少(P = .05),术后胃排空延迟更少(P = .05)。
  • 匹配后5年总生存(79% vs 75%;P = .74)与无复发生存(10% vs 17%;P = .39)相似。

核心结论

  • 作者认为,对于可切除左侧胰腺神经内分泌肿瘤患者,可安全地提出微创手术;微创手术降低主要并发症发生率,同时提供相当的长期肿瘤学结局。

研究设计与样本

  • 回顾性研究,分析法国21个中心2014年1月至2018年12月因可切除胰腺神经内分泌肿瘤行胰腺切除术的患者。
  • 共274例患者行左侧胰腺切除,其中109例行远端脾胰腺切除,165例行保留脾的远端胰腺切除(保留脾血管97例,58.7%;切除脾血管68例,41.3%)。
  • 基于肿瘤大小、性别、年龄、体重指数、中心和胰腺横断方式进行倾向性评分匹配,比较短期和长期结局。

主要发现

  • 倾向性评分匹配前,微创手术与较低的主要并发症发生率(P = .004)、较低的术后胃排空延迟发生率(P = .04)和较高的「教科书式」结局发生率(P = .04)相关。
  • 匹配后共2组各54例患者(远端脾胰腺切除30例;保留脾的远端胰腺切除78例)。
  • 匹配后微创手术与更少出血(P = .05)、更低的主要并发症发生率(6% vs 24%;P = .02)和更少的胃排空延迟(P = .05)相关,而术后胰瘘、出血和再手术率相似(P > .05)。
  • 匹配后5年总生存率(79% vs 75%;P = .74)和无复发生存率(10% vs 17%;P = .39)相似。

关键数值与推荐

  • 匹配后微创手术组主要并发症发生率为6%,开放手术组为24%(P = .02)。
  • 匹配后微创手术组5年总生存率为79%,开放手术组为75%(P = .74)。
  • 匹配后微创手术组5年无复发生存率为10%,开放手术组为17%(P = .39)。
  • 匹配后微创手术组出血更少(P = .05),胃排空延迟更少(P = .05),术后胰瘘、出血和再手术率相似(P > .05)。

临床怎么用

  • 作者认为,对于可切除左侧胰腺神经内分泌肿瘤患者,可安全地提出微创手术;微创手术降低主要并发症发生率,同时提供相当的长期肿瘤学结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive surgery has gained momentum for left pancreatic resections. However, debate remains about whether it has any advantage over open surgery for distal pancreatectomy for pancreatic neuroendocrine tumors. METHODS: This retrospective review examined pancreatectomies performed for resectable pancreatic neuroendocrine tumors at 21 centers in France between January 2014 and December 2018. Short and long-term outcomes were compared before and after propensity score matching based on tumor size, sex, age, body mass index, center, and method of pancreatic transection. RESULTS: During the period study, 274 patients underwent left pancreatic resection for pancreatic neuroendocrine tumors [109 underwent distal splenopancreatectomy, and 165 underwent spleen-preserving distal pancreatectomy [(splenic vessel preservation (n = 97; 58.7%)/splenic vessel resection (n = 68; 41.3%)]. Before propensity score matching, minimally invasive surgery was associated with a lower rate of major morbidity (P = .004), lower rate of postoperative delayed gastric emptying (P = .04), and higher rate of "textbook" outcomes (P = .04). After propensity score matching, there were 2 groups of 54 patients (n = 30 distal splenopancreatectomy; n = 78 spleen-preserving distal pancreatectomy). Minimally invasive surgery was associated with less blood loss (P = .05), decreased rate of major morbidity (6% vs. 24%; P = .02), less delayed gastric emptying (P = .05) despite similar rates of postoperative fistula, hemorrhage, and reoperation (P > .05). The 5-year overall survival (79% vs. 75%; P = .74) and recurrence-free survival (10% vs 17%; P = .39) were similar. CONCLUSION: Minimally invasive surgery for left pancreatic resection can be safely proposed for patients with resectable left pancreatic neuroendocrine tumors. Minimally invasive surgery decreases the rate of major complications while providing comparable long-term oncologic outcomes.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Addeo P, de Mathelin P, Doussot A, et al. Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study. Surgery. 2024. PMID: 38797604. doi:10.1016/j.surg.2024.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。